Showing results (131-140 of 175) with videos related to
Sort By:
Pageof 18
Clinical Rheumatology|December 16, 2014
The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal DiseasesMustafa Al Maini, Femi Adelowo, Jamal Al Saleh, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 1, 2017
A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid ArthritisMichael E Weinblatt, Clifton O Bingham, Gerd-Rüdiger Burmester, et al.Proceedings of the National Academy of Sciences of the United States of America|December 19, 2009
Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupusJens Y Humrich, Henner Morbach, Reinmar Undeutsch, et al.Arthritis and Rheumatism|September 8, 2011
Origin and functional activity of the membrane-bound glucocorticoid receptorCindy Strehl, Timo Gaber, Mark Löwenberg, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 20, 2019
Fra1 Controls Rheumatoid Factor Autoantibody Production by Bone Marrow Plasma Cells and the Development of Autoimmune Bone LossBettina Grötsch, Anja Lux, Yoann Rombouts, et al.International Journal of Molecular Sciences|March 12, 2017
A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted PatientsPaula Hoff, Timo Gaber, Cindy Strehl, et al.Clinical and Experimental Rheumatology|April 27, 2019
Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI)Thomas Dörner, Hendrik Schulze-Koops, Gerd-Rüdiger Burmester, et al.Cellular & Molecular Immunology|February 12, 2013
Human immune cells' behavior and survival under bioenergetically restricted conditions in an in vitro fracture hematoma modelPaula Hoff, Patrick Maschmeyer, Timo Gaber, et al.Annals of the Rheumatic Diseases|March 15, 2022
Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseasesAmanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik N Albach, et al.Arthritis Research & Therapy|October 13, 2016
Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritisStefan Vordenbäumen, Angelika Lueking, Petra Budde, et al.Pageof 18